Comparative study of serum fasting blood glucose level, insulin resistance, serum thyroid stimulating hormone level, serum ferritin level and serum gama amino butyric acid level in diagnosed polycystic ovarian syndrome patients

Nitu Choudhary; Sanjiv Kumar Bansal; Nisha Chauhan; Bindoo Yadav

doi:10.53730/ijhs.v6nS7.14017

Authors

Nitu Choudhary PhD Scholar Department of Biochemistry Faculty of Medicine and Health Sciences, SGT University, Budhera, Gurugram, Haryana
Sanjiv Kumar Bansal
editorsloap@gmail.com
Professor and associate Dean, Department of Biochemistry Faculty of Medicine and Health Sciences, SGT University, Budhera, Gurugram, Haryana
Nisha Chauhan PhD Scholar Department of Biochemistry Faculty of Medicine and Health Sciences, SGT University, Budhera, Gurugram, Haryana
Bindoo Yadav Professor Department of Obstetrics and Gynaecology Faculty of Medicine and Health Sciences, SGT University, Budhera, Gurugram, Haryana

Keywords:

Polycystic ovarian syndrome, Insulin resistance, HOMA-IR, Ferritin, TSH

Abstract

Aim and Objective: To evaluate to evaluate the levels of Serum Fasting blood glucose, IR, Serum TSH, Serum Ferritin and Serum GABA in diagnosed PCOS patients and normal controls. Methods: The study was conducted on 160 subjects aged between 18 to 45 years comprising of 80 healthy control and 80 patients with clinically diagnosed cases of PCOS, acted as study group. The blood samples of controls as well as study groups were withdrawn and Clinical evaluation included anthropometry, Height, Weight, Body Mass Index (BMI) and waist-to-hip ratio (WHR) were calculated. Circulating levels of fasting glucose, insulin resistance, Serum Thyroid stimulating hormone level, Serum Ferritin level and Serum Gama amino butyric acid level were determined by Chemiluminescence based immunoassay (CLIA) on fully automated Biochemistry analyzer MAGLUMI 1000. Results: Total 160 subjects with both control and study group PCOS patients were included in the study. The age of these control group was ranged from 18 to 45 years, with a mean of 26.23±5.58 years and PCOS study were found 27.76 ±6.54 years. The findings of anthropometric measurements of the subjects of both PCOS syndrome (n=80) and non-PCOS (n=80).

Downloads

Download data is not yet available.

References

Wilson MS, Thompson EW. Venesection is an effective non-pharmacological treatment for patients with high serum ferritin type 2 diabetes. J Clinical Translational Endocrinol Case Rep. 2017;3:1-5.

Tuomainen TP, Nyyssonen K, Salonen R, Tervahauta A, Korpela H, Lakka T, et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care. 1997;20(3):426-8.

Le TD, Bae S, Ed HC, Singh KP, Blair SN, Shang N. Effects of Cardiorespiratory Fitness on Serum Ferritin Concentration and Incidence of Type 2 Diabetes: Evidence from the Aerobics Center Longitudinal Study (ACLS). Rev Diabet Stud. 2008;5(4):245-52.

Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774-800.

March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544-51.

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7.

Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, et al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod. 2014;29(4):791-801.

Unluturk U, Harmanci A, Kocaefe C, Yildiz BO. The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma. PPAR Res. 2007;49109.

Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2012;(5):3053.

Jakubowicz D, Wainstein J, Homburg R. The link between polycystic ovarian syndrome and type 2 diabetes: preventive and therapeutic approach in Israel. Isr Med Assoc J. 2012;14(7):442-7.

Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update. 2010;16(4):347-63.

Lim SS, Davies M J, Norman R J, and Moran L J Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update. 2012;18(6):618-37.

Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.

Lee H, Oh JY, Sung YA, Chung H. Is insulin resistance an intrinsic defect in asian polycystic ovary syndrome?. Yonsei Med J. 2013;54(3):609-14.

Wang HS, Wang TH. Polycystic ovary syndrome (PCOS), insulin resistance and insulin-like growth factors (IGfs)/IGF-binding proteins (IGFBPs). Chang Gung Med J. 2003;26(8):540-53.

Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981-1030.

Dumitrescu R, Mehedintu C, Briceag I, Purcarea VL, Hudita D. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms. J Med Life. 2015;8(2):142-5.

Sakumoto T, Tokunaga Y, Terada Y, Tanaka H, Nohara M, Nakaza A, et al. Implications of Insulin Resistance/Hyperinsulinemia on Reproductive Function in Infertile Women with Polycystic Ovary Syndrome. 2012.

Zamily HA. Iron Status and Lipid Profile in Irregular Cycle Women with Polycystic Ovary Syndrome. Int J Sci Res. 2015;4(10):1153-58.

Jehn M, Jeanne MC, Guallar E. Serum ferritin and risk of metabolic syndrome in U.S. adults. Diabetes Care. 2004;27:2422-28.

Emma A. Ferritin (serum, plasma). Association for Clinical Biochem. 2012;1-8.

Acton RT, Barton JC, Barton JC. Serum ferritin, insulin resistance, and metabolic syndrome: clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS study. Metab Syndr Relat Disord. 2015;13(2):57-63.

Huang J, Karnchanasorn R, Ou HY, Feng W, Chuang LM, Chiu KC, et al. Association of insulin resistance with serum ferritin and aminotransferases-iron hypothesis. World J Exp Med. 2015;5(4):232-43.

Yousouf R, Khan M, Kounsar Z, Ahanga S, Lone A W. Polycystic Ovarian Syndrome: Clinical Correlation with Biochemical Status. Surgical Sci. 2012;3:245-8.

Wen PC, Cheng TYD, Tsai SP, Chan HT, Hsu HL, Hsu CC, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutrition. 2008; 12(4):497-506.

Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS, et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin- dependent diabetes mellitus. J Clinical Investig. 1995;96(1):520-7.

Pedersen SD, Brar S, Faris P, Corenblum B. Polycystic ovary syndrome: validated questionnaire for use in diagnosis. Can Fam Physician. 2007;53(6):1042-7.

Faranak S, Sahar M, Nouraddin M. High Serum Ferritin Concentrations in Polycystic Ovary Syndrome Is Not Related to Insulin Resistance. Iranian J Diabet Obesity. 2011;3(2):47-53.

Jung CH, Lee MJ, Hwang JY, Jang JE, Leem J. Elevated Serum Ferritin Level Is Associated with the Incident Type 2 Diabetes in Healthy Korean Men: A 4 Year Longitudinal Study. PLoS ONE. 2013;8(9):75250.

Morreale HF, Ramirez M, Blasco F, Carretero JI, Sancho J, Millan JL. Body iron stores are increased in overweight and obese women with polycystic ovary syndrome. Diabetes Care. 2005;28(8):2042-4.

Morreale HF. Iron metabolism and the polycystic ovary syndrome. Trends Endocrinol Metab. 2012;23(10):509-15. 3. Ko PC, Huang SY, Hsieh CH, Hsu MI, Hsu CS. Serum ferritin levels and polycystic ovary syndrome in obese and nonobese women. Taiwan J Obstet Gynecol. 2015;54(4):403-7.

Crownover BK, Covey CJ. Hereditary hemochromatosis. Am Fam Physician. 2013;87(3):183-90.